What Is CJC Ipamorelin? A Guide to the CJC-1295 and Ipamorelin Stack

CJC ipamorelin is a two-peptide stack made up of CJC-1295 and ipamorelin, used in an attempt to raise growth hormone (GH) levels. CJC-1295 mimics growth hormone-releasing hormone (GHRH) and ipamorelin mimics ghrelin, so the two act on different receptors and are frequently combined. Neither peptide is FDA-approved for human use in the United States.

What Is CJC Ipamorelin Exactly?

CJC ipamorelin is not a single drug. It is shorthand for a combination of two separate peptides that are almost always discussed as a pair. Understanding what is cjc 1295 peptide starts with the fact that it is a modified GHRH analog built to last longer in the body than natural GHRH.

Ipamorelin is a growth hormone secretagogue, a synthetic peptide that signals the pituitary gland to release GH. It was designed to be more selective than older secretagogues, with less impact on cortisol and appetite hormones in early research.

Many people search what is cjc-1295 ipamorelin after hearing the two names used interchangeably. In practice they are different molecules, dosed on different schedules, that are often drawn into the same syringe.

How CJC-1295 and Ipamorelin Work Together

GH release is controlled by several signals at once. GHRH sets the baseline, ghrelin triggers pulses, and somatostatin acts as the brake. CJC-1295 fills the first role and ipamorelin fills the second.

Because the mechanisms differ, researchers have asked whether combining them produces a larger GH pulse than either peptide alone. Small studies on GHRH analogs and ghrelin mimetics support that idea, but the specific CJC-1295 plus ipamorelin stack has not been tested in large controlled human trials.

Feature	CJC-1295	Ipamorelin
Receptor target	GHRH receptor	Ghrelin / GHS-R1a receptor
Typical half-life	About 6 to 8 days with DAC; about 30 minutes without	Roughly 2 hours
Described in research as	Raises baseline GH and IGF-1	Produces a GH pulse with less cortisol or appetite effect
Dosing patterns discussed online	1 to 2 mg once or twice weekly (with DAC)	100 to 200 mcg two to three times daily
FDA-approved for human use	No	No

The dosing figures above come from research papers and vendor labels, not from FDA-approved prescribing information. They are not a recommendation, and self-dosing with unapproved peptides carries real risk.

CJC-1295 With DAC vs Without DAC

CJC-1295 comes in two versions, and the difference matters. The DAC version (drug affinity complex) binds to albumin in the blood, which stretches its half-life to roughly a week. The version without DAC behaves more like natural GHRH and clears in about half an hour.

If you have seen the phrase what is cjc-1295 ipamorelin no dac, it refers to that short-acting form, which is usually paired with more frequent injections. Long-acting CJC-1295 stays active around the clock, which is a very different exposure pattern.

Version	Half-life	Typical pairing	Main trade-off
CJC-1295 with DAC	About 6 to 8 days	Often stacked with ipamorelin	Constant GH elevation instead of natural pulses
CJC-1295 without DAC (mod GRF 1-29)	About 30 minutes	Usually stacked with ipamorelin	More frequent dosing but closer to natural pulses

What Is CJC 1295 Ipamorelin Used For?

Online, this stack is marketed for fat loss, muscle gain, better sleep, joint recovery, and anti-aging. The evidence behind those claims is thin and mostly indirect.

The next question people ask is usually what is cjc 1295 ipamorelin used for, and the honest answer is that most uses rest on small, short studies of the individual peptides, not the combination, and rarely in healthy adults.

What the research does support:

• GHRH analogs raise GH and IGF-1 levels in the blood.
• Ipamorelin stimulates GH release with relatively little effect on cortisol or prolactin in animal and early human studies.
• Raising GH does not automatically change body composition, and supraphysiologic GH comes with real side effects.

It is worth saying plainly: these peptides are not proven treatments for obesity, injury, or aging, and no major medical organization recommends them for those purposes.

Is CJC-1295/Ipamorelin FDA-Approved?

No. Neither CJC-1295 nor ipamorelin is FDA-approved for human use in the United States, and the combination is not either. For anyone typing is cjc-1295/ipamorelin fda-approved, the answer is a flat no.

Both are sold as research chemicals or products labeled not for human consumption, which is a legal category rather than a safety endorsement. Products from those channels are not required to meet the purity, sterility, or labeling standards of approved drugs, and independent testing has repeatedly found mislabeled or contaminated peptides.

Growth hormone secretagogues also appear on the World Anti-Doping Agency prohibited list, which matters for anyone subject to drug testing.

Side Effects and Safety Concerns

Reported side effects include injection site reactions, headache, flushing, water retention, joint aches, and changes in hunger. Most are described as mild and temporary, but the data come largely from short studies.

More serious unknowns deserve attention:

• Long-term GH and IGF-1 elevation is associated with insulin resistance, edema, and in some contexts increased cancer risk.
• Exogenous GH signals can suppress the body's own GH axis, and it is unclear how fully that recovers.
• Unapproved peptides offer no guaranteed dose accuracy, and sterility problems can cause infection.

Anyone considering CJC-1295 and ipamorelin should talk with a licensed healthcare professional first, especially with a history of cancer, diabetes, or pituitary disease.

Bottom Line

CJC ipamorelin is a research peptide stack, not an approved therapy. CJC-1295 supplies a GHRH signal and ipamorelin supplies a ghrelin signal, and the pair is studied for raising GH, a goal that has not been shown to deliver the body-composition and anti-aging results people advertise.

If a clinic or vendor promises FDA-approved CJC-1295 and ipamorelin, that is a red flag. These compounds are sold for research use only and are not cleared for human use in the US.

COMMON QUESTIONS

Frequently Asked Questions

Is CJC-1295 the same as ipamorelin?

No. CJC-1295 and ipamorelin are two different peptides that act on different receptors. CJC-1295 targets the GHRH receptor and lasts for days, while ipamorelin targets the ghrelin receptor and clears in a couple of hours. They are often stacked together, which is why the names get merged into one search term.

What are the side effects of CJC-1295 and ipamorelin?

Commonly reported effects include injection site irritation, headache, flushing, water retention, joint aches, and appetite changes. Because these peptides raise GH and IGF-1, longer-term concerns include insulin resistance, edema, and possible cancer risk, and there is no large safety database for the combination in humans. Anyone with a history of cancer, diabetes, or pituitary disease should speak with a doctor before considering them.

Is CJC-1295 ipamorelin legal to buy in the US?

Neither peptide is FDA-approved for human use, so they cannot be sold as drugs or dietary supplements. They are typically marketed as research chemicals labeled not for human consumption, and products from that market are not required to meet drug-level purity or sterility standards. These peptides are also banned by the World Anti-Doping Agency for athletes subject to testing.